Legal
FTC Warns 24 Healthcare Giants Over Price Transparency Compliance
In a Volkov Law Group analysis, the firm reports that the Federal Trade Commission sent warning letters on October 5 to 24 of the nation's largest healthcare services companies, stating that mere compliance with CMS price transparency rules does not satisfy separate legal obligations to provide patients with timely, accurate, and complete pricing information. The FTC warned that failing to meet these obligations can constitute an unfair or deceptive practice under Section 5 of the FTC Act, exposing companies to enforcement action independent of CMS requirements. The letters signal that the FTC views pricing transparency as both a consumer protection and antitrust issue, not solely a CMS compliance matter.
Why it mattersHealthcare organizations, including Medicaid managed care plans and providers, face dual exposure to CMS and FTC enforcement over pricing transparency, meaning CMS rule compliance alone no longer insulates them from federal action.